Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Teva Nominates Former Leumi Chief Galia Maor for Board

(Corrects spelling of chairman’s name in third paragraph.)

Aug. 8 (Bloomberg) -- Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, nominated Galia Maor, the former Bank Leumi Le-Israel Ltd. chief executive officer, to its board of directors.

The company will ask shareholders to approve the nomination at a Sept. 12 meeting, Teva said in a filing. Maor stepped down as CEO of Israel’s largest lender by assets this year after 16 years in the role, in which she was one of the nation’s most prominent female business leaders.

Maor may be a candidate to replace Phillip Frost as chairman of Petach Tikva, Israel-based Teva, Maariv reported on July 25. Maor has the support of directors Amir Elstein and Chaim Hurvitz, the newspaper said, citing people at Teva it didn’t identify.

To contact the reporter on this story: David Wainer in Tel Aviv at

To contact the editor responsible for this story: Phil Serafino at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.